MET and neoplasm: The c-Met signaling pathway has been reported to be inappropriately activated in many human solid malignancies and to regulate tumor formation, survival, proliferation, motility, and morphogenesis, which correlate with poor prognosis and even affect tumor metastasis and resistance to target therapy [9,10,11].